ATEROMA 40 MG COM REV CT BL AL/AL X 10

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1037202630093
  • GGREM 542615060004603
  • Código de barras 7898943707123

O que a fonte publica

Detentor do registro
SUPERA FARMA LABORATÓRIOS S.A
Princípios ativos
ATORVASTATINA CÁLCICA
Embalagem
40 MG COM REV CT BL AL/AL X 10
Tipo de produto
Similar
Classe terapêutica
C10A1 - ESTATINAS, INIBIDORES DA REDUTASE HMG-CoA

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:542615060004603
{
  "name": "ATEROMA 40 MG COM REV CT BL AL/AL X 10",
  "holder": "SUPERA FARMA LABORATÓRIOS S.A",
  "stripe": null,
  "barcodes": [
    "7898943707123"
  ],
  "confaz87": true,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "542615060004603",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "43.312.503/0001-05",
  "priceRegime": "Regulado",
  "productName": "ATEROMA",
  "productType": "Similar",
  "hospitalOnly": false,
  "presentation": "40 MG COM REV CT BL AL/AL X 10",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "41.39",
    "icms-12": "47.03",
    "icms-17": "49.87",
    "icms-18": "50.48",
    "icms-19": "51.10",
    "icms-20": "51.74",
    "icms-21": "52.39",
    "icms-22": "53.06",
    "icms-23": "53.75",
    "icms-17.5": "50.17",
    "icms-19.5": "51.42",
    "icms-20.5": "52.06",
    "icms-22.5": "53.41",
    "icms-12-alc": "46.47",
    "icms-17-alc": "49.27",
    "icms-18-alc": "49.87",
    "icms-19-alc": "50.49",
    "icms-20-alc": "51.12",
    "icms-21-alc": "51.76",
    "icms-22-alc": "52.43",
    "icms-23-alc": "53.11",
    "withoutTaxes": "40.89",
    "icms-17.5-alc": "49.57",
    "icms-19.5-alc": "50.80",
    "icms-20.5-alc": "51.44",
    "icms-22.5-alc": "52.77"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "ATORVASTATINA CÁLCICA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "57.05",
    "icms-12": "64.83",
    "icms-17": "68.74",
    "icms-18": "69.58",
    "icms-19": "70.44",
    "icms-20": "71.32",
    "icms-21": "72.21",
    "icms-22": "73.14",
    "icms-23": "74.09",
    "icms-17.5": "69.15",
    "icms-19.5": "70.88",
    "icms-20.5": "71.76",
    "icms-22.5": "73.62",
    "icms-12-alc": "64.24",
    "icms-17-alc": "68.11",
    "icms-18-alc": "68.94",
    "icms-19-alc": "69.80",
    "icms-20-alc": "70.67",
    "icms-21-alc": "71.56",
    "icms-22-alc": "72.48",
    "icms-23-alc": "73.42",
    "withoutTaxes": "56.53",
    "icms-17.5-alc": "68.53",
    "icms-19.5-alc": "70.23",
    "icms-20.5-alc": "71.11",
    "icms-22.5-alc": "72.95"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "ATORVASTATINA CÁLCICA"
  ],
  "therapeuticClass": "C10A1 - ESTATINAS, INIBIDORES DA REDUTASE HMG-CoA",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1037202630093",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "C10A1",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:542615060004603"